Soni Manmeet Singh
SEC-identified person · CIK 1569769 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Pulse Biosciences, Inc. PLSE | Director | filed 2017 - 2026 |
| Summit Therapeutics Inc. SMMT | Director · Chief Operating Officer | filed 2020 - 2026 |
| Reata Pharmaceuticals INC RETA | Chief Financial Officer | filed 2019 - 2023 |
| Arena Pharmaceuticals INC ARNA | Director | filed 2018 - 2020 |
| Alnylam Pharmaceuticals, INC. ALNY | Chief Financial Officer | filed 2017 - 2019 |
| Ariad Pharmaceuticals INC ARIA | EVP, CFO & Treasurer | filed 2016 - 2017 |
| Pharmacyclics INC pcyc | VP, Corporate Controller | filed 2013 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.